Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
300
-
Total 13F shares, excl. options
-
113M
-
Shares change
-
-1.56M
-
Total reported value, excl. options
-
$5.69B
-
Value change
-
-$78.6M
-
Put/Call ratio
-
1.2
-
Number of buys
-
119
-
Number of sells
-
-149
-
Price
-
$50.30
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q4 2017
370 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q4 2017.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 300 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 113M shares
of 159M outstanding shares and own 71.37% of the company stock.
Largest 10 shareholders include FMR LLC (18.7M shares), Clearbridge Investments, LLC (11M shares), WELLINGTON MANAGEMENT GROUP LLP (10.9M shares), Vanguard Group Inc (10.1M shares), BB BIOTECH AG (8.14M shares), BlackRock Inc. (6.97M shares), BAILLIE GIFFORD & CO (6.61M shares), WADDELL & REED FINANCIAL INC (4.53M shares), STATE STREET CORP (2.75M shares), and OppenheimerFunds, Inc. (2.69M shares).
This table shows the top 300 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.